ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $695,208 | -21.9% | 127,561 | -3.9% | 0.00% | 0.0% |
| Q2 2023 | $890,645 | -17.7% | 132,734 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $1,082,567 | +19.4% | 122,601 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $906,799 | +29.5% | 118,691 | +20.6% | 0.00% | 0.0% |
| Q3 2022 | $700,000 | -4.4% | 98,387 | +8.7% | 0.00% | 0.0% |
| Q2 2022 | $732,000 | -39.9% | 90,513 | +3.1% | 0.00% | 0.0% |
| Q1 2022 | $1,218,000 | -44.1% | 87,793 | +13.2% | 0.00% | 0.0% |
| Q4 2021 | $2,177,000 | -26.5% | 77,567 | -10.9% | 0.00% | -50.0% |
| Q3 2021 | $2,960,000 | -14.2% | 87,086 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $3,450,000 | +7.6% | 84,430 | +6.0% | 0.00% | 0.0% |
| Q1 2021 | $3,207,000 | -22.5% | 79,663 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $4,139,000 | +27.0% | 69,988 | +4.5% | 0.00% | 0.0% |
| Q3 2020 | $3,258,000 | -53.4% | 66,993 | -53.6% | 0.00% | -60.0% |
| Q2 2020 | $6,992,000 | +3049.5% | 144,527 | +1705.7% | 0.01% | – |
| Q1 2020 | $222,000 | -92.5% | 8,004 | -86.9% | 0.00% | -100.0% |
| Q2 2019 | $2,946,000 | – | 61,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |